{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:08:37Z","timestamp":1762459717560,"version":"3.37.3"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01 ES-11740"],"award-info":[{"award-number":["R01 ES-11740"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA135679","CA133099","CA186261-01A1"],"award-info":[{"award-number":["CA135679","CA133099","CA186261-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Because lymphocyte telomere length (LTL) plays critical roles in the maintenance of genomic stability and integrity, LTL thus may influence the etiology and prognosis of squamous cell carcinoma of the oropharynx (SCCOP). However, given the association between LTL and risk of human papillomavirus (HPV)-associated SCCOP and between LTL and tumor HPV status of SCCOP, we hypothesized that LTL is associated with SCCOP prognosis, particularly in HPV-positive patients after definitive radiotherapy. LTL and tumor HPV type 16 (HPV16) status were determined in 564 incident SCCOP patients before radiotherapy or chemoradiation. Both univariate and multivariable Cox regression analyses were performed to estimate the association between LTL and prognosis. Eighty-five percent patients had HPV16-positive tumors. Patients with shorter telomeres had significantly better overall, disease-specific and disease-free survival than did those with longer telomeres (log-rank P &lt; 0.001). Moreover, patients with shorter telomeres had significantly lower risk of death overall [hazard ratio (HR) = 0.2; 95% confidence interval (CI) = 0.1\u20130.4], death due to SCCOP (HR = 0.2; 95% CI = 0.1\u20130.4) and SCCOP recurrence (HR = 0.3; 95% CI = 0.2\u20130.5) after adjusting for other important prognostic confounders. Finally, we found more pronounced effects of LTL on survival in HPV16-positive SCCOP patients after stratified analysis according to tumor HPV status. These findings indicate that LTL plays a significant role in the survival of patients with SCCOP, especially HPV16-positive patients who undergo definitive radiotherapy. Therefore, pretreatment LTL may be an independent prognostic biomarker for HPV16-positive SCCOP. Prospective studies with larger sample sizes are needed to confirm these findings.<\/jats:p>","DOI":"10.1093\/carcin\/bgz019","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T20:19:10Z","timestamp":1548793150000},"page":"735-741","source":"Crossref","is-referenced-by-count":4,"title":["Lymphocyte telomere length predicts clinical outcomes of HPV-positive oropharyngeal cancer patients after definitive radiotherapy"],"prefix":"10.1093","volume":"40","author":[{"given":"Xiaoning","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"},{"name":"Department of Otolaryngology-Head and Neck Surgery, Guangdong provincial people\u2019s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich M","family":"Sturgis","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"},{"name":"Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"},{"name":"Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Otolaryngology Head and Neck Surgery, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"},{"name":"Department of Otorhinolaryngology and Head and Neck Surgery, Yuhuangding Hospital of Qingdao University, Yantai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhensheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4115-4439","authenticated-orcid":false,"given":"Qingyi","family":"Wei","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-1502","authenticated-orcid":false,"given":"Guojun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"},{"name":"Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"2019070605525044100_CIT0001","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/lary.25767","article-title":"The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer","volume":"126","author":"Gooi","year":"2016","journal-title":"Laryngoscope"},{"key":"2019070605525044100_CIT0002","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hed.22015","article-title":"Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer\u2013systematic review and meta-analysis of trends by time and region","volume":"35","author":"Mehanna","year":"2013","journal-title":"Head Neck"},{"key":"2019070605525044100_CIT0003","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"2019070605525044100_CIT0004","doi-asserted-by":"crossref","first-page":"665","DOI":"10.6004\/jnccn.2011.0055","article-title":"The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms?","volume":"9","author":"Sturgis","year":"2011","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"2019070605525044100_CIT0005","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1200\/JCO.2014.55.1937","article-title":"Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma","volume":"32","author":"Fakhry","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"2019070605525044100_CIT0006","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2014.55.3925","article-title":"Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity","volume":"32","author":"Nguyen-Tan","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"2019070605525044100_CIT0007","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.radonc.2011.02.010","article-title":"The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial","volume":"100","author":"Lassen","year":"2011","journal-title":"Radiother. Oncol."},{"key":"2019070605525044100_CIT0008","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/annonc\/mdr006","article-title":"Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial","volume":"22","author":"Posner","year":"2011","journal-title":"Ann. Oncol."},{"key":"2019070605525044100_CIT0009","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1200\/JCO.2010.29.2904","article-title":"Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial","volume":"28","author":"Rischin","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"2019070605525044100_CIT0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"2019070605525044100_CIT0011","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/cncr.10257","article-title":"Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues","volume":"94","author":"Nguyen","year":"2002","journal-title":"Cancer"},{"key":"2019070605525044100_CIT0012","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1200\/JCO.2015.61.2358","article-title":"Human papillomavirus-associated oropharyngeal cancer: defining risk groups and clinical trials","volume":"33","author":"Bhatia","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"2019070605525044100_CIT0013","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1073\/pnas.85.18.6622","article-title":"A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes","volume":"85","author":"Moyzis","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2019070605525044100_CIT0014","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.arr.2013.01.003","article-title":"A systematic review of leukocyte telomere length and age in adults","volume":"12","author":"M\u00fcezzinler","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"2019070605525044100_CIT0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/epirev\/mxs008","article-title":"Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither?","volume":"35","author":"Sanders","year":"2013","journal-title":"Epidemiol. Rev."},{"key":"2019070605525044100_CIT0016","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mrfmmm.2011.08.003","article-title":"Telomeres and lifestyle factors: roles in cellular aging","volume":"730","author":"Lin","year":"2012","journal-title":"Mutat. Res."},{"key":"2019070605525044100_CIT0017","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jdermsci.2015.08.003","article-title":"Telomere length and the risk of cutaneous melanoma and non-melanoma skin cancer: a review of the literature and meta-analysis","volume":"80","author":"Caini","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"2019070605525044100_CIT0018","doi-asserted-by":"crossref","first-page":"42468","DOI":"10.18632\/oncotarget.6468","article-title":"Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk","volume":"6","author":"Walsh","year":"2015","journal-title":"Oncotarget"},{"key":"2019070605525044100_CIT0019","doi-asserted-by":"crossref","first-page":"e20466","DOI":"10.1371\/journal.pone.0020466","article-title":"Shortened telomere length is associated with increased risk of cancer: a meta-analysis","volume":"6","author":"Ma","year":"2011","journal-title":"PLoS One"},{"key":"2019070605525044100_CIT0020","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1158\/1055-9965.EPI-11-0005","article-title":"The association of telomere length and cancer: a meta-analysis","volume":"20","author":"Wentzensen","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"2019070605525044100_CIT0021","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jnci\/djg011","article-title":"Telomere dysfunction: a potential cancer predisposition factor","volume":"95","author":"Wu","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"2019070605525044100_CIT0022","doi-asserted-by":"crossref","first-page":"e0133174","DOI":"10.1371\/journal.pone.0133174","article-title":"The association between telomere length and cancer prognosis: evidence from a meta-analysis","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"2019070605525044100_CIT0023","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jnci\/djt016","article-title":"Short telomere length, cancer survival, and cancer risk in 47102 individuals","volume":"105","author":"Weischer","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"2019070605525044100_CIT0024","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1128\/JVI.02556-08","article-title":"NFX1-123 increases hTERT expression and telomerase activity posttranscriptionally in human papillomavirus type 16 E6 keratinocytes","volume":"83","author":"Katzenellenbogen","year":"2009","journal-title":"J. Virol."},{"key":"2019070605525044100_CIT0025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.virol.2008.02.025","article-title":"HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function","volume":"375","author":"Liu","year":"2008","journal-title":"Virology"},{"key":"2019070605525044100_CIT0026","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.1128\/JVI.75.15.7198-7201.2001","article-title":"E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc","volume":"75","author":"Gewin","year":"2001","journal-title":"J. Virol."},{"key":"2019070605525044100_CIT0027","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1128\/JVI.75.9.4467-4472.2001","article-title":"Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein","volume":"75","author":"Veldman","year":"2001","journal-title":"J. Virol."},{"key":"2019070605525044100_CIT0028","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1158\/0008-5472.CAN-13-0881","article-title":"Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma","volume":"73","author":"Zhang","year":"2013","journal-title":"Cancer Res."},{"key":"2019070605525044100_CIT0029","doi-asserted-by":"crossref","first-page":"E251","DOI":"10.1002\/ijc.27335","article-title":"Combined p53-related genetic variants together with HPV infection increase oral cancer risk","volume":"131","author":"Wang","year":"2012","journal-title":"Int. J. Cancer"},{"key":"2019070605525044100_CIT0030","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.291.20.2441","article-title":"Prognostic importance of comorbidity in a hospital-based cancer registry","volume":"291","author":"Piccirillo","year":"2004","journal-title":"JAMA"},{"key":"2019070605525044100_CIT0031","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/1078-0432.CCR-09-2877","article-title":"Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer","volume":"16","author":"Guan","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"2019070605525044100_CIT0032","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1158\/0008-5472.CAN-09-4595","article-title":"Telomere length in prospective and retrospective cancer case-control studies","volume":"70","author":"Pooley","year":"2010","journal-title":"Cancer Res."},{"key":"2019070605525044100_CIT0033","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1158\/1055-9965.EPI-06-0961","article-title":"Telomere length, cigarette smoking, and bladder cancer risk in men and women","volume":"16","author":"McGrath","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"2019070605525044100_CIT0034","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1158\/1055-9965.EPI-11-0890","article-title":"Telomere length and TERT functional polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck","volume":"20","author":"Liu","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"2019070605525044100_CIT0035","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1158\/1055-9965.EPI-10-0281","article-title":"No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk","volume":"19","author":"Pooley","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"2019070605525044100_CIT0036","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/461706a","article-title":"Chromosome protection scoops nobel","volume":"461","author":"Abbott","year":"2009","journal-title":"Nature"},{"key":"2019070605525044100_CIT0037","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.326_212","article-title":"Physiology nobel. U.S. researchers recognized for work on telomeres","volume":"326","author":"Vogel","year":"2009","journal-title":"Science"},{"key":"2019070605525044100_CIT0038","first-page":"3079","article-title":"Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ","volume":"7","author":"Kim","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"2019070605525044100_CIT0039","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1258\/0956462991913367","article-title":"Increased telomerase activity and decreased telomere length in genital condylomata acuminata","volume":"10","author":"Rahat","year":"1999","journal-title":"Int. J. STD AIDS"},{"key":"2019070605525044100_CIT0040","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/cncr.29323","article-title":"Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer","volume":"121","author":"Guo","year":"2015","journal-title":"Cancer"},{"key":"2019070605525044100_CIT0041","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2012.44.0164","article-title":"Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis","volume":"31","author":"Kim","year":"2013","journal-title":"J Clin Oncol."},{"key":"2019070605525044100_CIT0042","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"2019070605525044100_CIT0043","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/ijc.24911","article-title":"Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma","volume":"126","author":"Jung","year":"2010","journal-title":"Int. J. Cancer"},{"key":"2019070605525044100_CIT0044","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/annonc\/mdu016","article-title":"Short leukocyte telomere length predicts poor prognosis and indicates altered immune functions in colorectal cancer patients","volume":"25","author":"Chen","year":"2014","journal-title":"Ann. Oncol."},{"key":"2019070605525044100_CIT0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/cncr.21625","article-title":"Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma","volume":"106","author":"Garcia-Aranda","year":"2006","journal-title":"Cancer"},{"key":"2019070605525044100_CIT0046","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000438614","article-title":"Telomere length as a prognostic factor for overall survival in colorectal cancer patients","volume":"38","author":"Jia","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"2019070605525044100_CIT0047","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/0008-5472.CAN-07-6497","article-title":"Breast cancer survival is associated with telomere length in peripheral blood cells","volume":"68","author":"Svenson","year":"2008","journal-title":"Cancer Res."},{"key":"2019070605525044100_CIT0048","doi-asserted-by":"crossref","first-page":"dju035","DOI":"10.1093\/jnci\/dju035","article-title":"Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors","volume":"106","author":"Duggan","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"2019070605525044100_CIT0049","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10549-012-2058-9","article-title":"Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival","volume":"134","author":"Shen","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"2019070605525044100_CIT0050","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/bcr2893","article-title":"Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome","volume":"13","author":"Lu","year":"2011","journal-title":"Breast Cancer Res."},{"key":"2019070605525044100_CIT0051","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.leukres.2015.09.015","article-title":"Impact of telomere length on survival in classic and variant hairy cell leukemia","volume":"39","author":"Arons","year":"2015","journal-title":"Leuk. Res."},{"key":"2019070605525044100_CIT0052","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13046-015-0195-9","article-title":"Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status","volume":"34","author":"Fern\u00e1ndez-Marcelo","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2019070605525044100_CIT0053","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.18632\/oncotarget.6007","article-title":"TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"2019070605525044100_CIT0054","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/cncr.28797","article-title":"High-risk human papillomavirus infection associated with telomere elongation in patients with esophageal squamous cell carcinoma with poor prognosis","volume":"120","author":"Zhang","year":"2014","journal-title":"Cancer"},{"key":"2019070605525044100_CIT0055","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00439-015-1563-4","article-title":"Telomere length and common disease: study design and analytical challenges","volume":"134","author":"Barrett","year":"2015","journal-title":"Hum. Genet."},{"key":"2019070605525044100_CIT0056","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tig.2013.06.007","article-title":"Telomerase at the intersection of cancer and aging","volume":"29","author":"Bernardes de Jesus","year":"2013","journal-title":"Trends Genet."}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/40\/6\/735\/28911729\/bgz019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T05:23:20Z","timestamp":1606281800000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/40\/6\/735\/5306965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":56,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,2,5]]},"published-print":{"date-parts":[[2019,7,6]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgz019","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"type":"print","value":"0143-3334"},{"type":"electronic","value":"1460-2180"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,2,5]]}}}